Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04848727 · ClinicalTrials.gov registry record
Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants
A clinical trial, sponsored by Sharp HealthCare.
- Completed
- Registry status
- 20
- Enrollment target
NCT04848727: Completed study, sponsored by Sharp HealthCare.
NCT04848727 is a clinical trial that has completed, run by Sharp HealthCare. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04848727 has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
To validate the benefits of recognizing asymmetric lung disease like atelectasis and pneumothorax in neonatal respiratory distress syndrome using electrical impedance tomography
Interventions
- OTHER Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2022-06-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04848727
The ClinicalTrials.gov registry entry for NCT04848727 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT) is the first listed.
NCT04848727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04848727 about?
NCT04848727 is a clinical study titled "Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants". To validate the benefits of recognizing asymmetric lung disease like atelectasis and pneumothorax in neonatal respiratory distress syndrome using electrical impedance tomography
What is the current status of trial NCT04848727?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-08-06. Estimated completion is 2022-06-07.
What interventions are being tested in trial NCT04848727?
The interventions under investigation include: Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT) (OTHER).
Who is sponsoring clinical trial NCT04848727?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.